Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Published:2016-06 Issue:10038 Volume:387 Page:2630-2640
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Khanna Dinesh,Denton Christopher P,Jahreis Angelika,van Laar Jacob M,Frech Tracy M,Anderson Marina E,Baron Murray,Chung Lorinda,Fierlbeck Gerhard,Lakshminarayanan Santhanam,Allanore Yannick,Pope Janet E,Riemekasten Gabriela,Steen Virginia,Müller-Ladner Ulf,Lafyatis Robert,Stifano Giuseppina,Spotswood Helen,Chen-Harris Haiyin,Dziadek Sebastian,Morimoto Alyssa,Sornasse Thierry,Siegel Jeffrey,Furst Daniel E

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Epidemiology of systemic sclerosis;Nikpour;Best Practice Res Clin Rheumatol,2010

2. Interleukin-6: a new therapeutic target in systemic sclerosis?;O'Reilly;Clin Transl Immunol,2013

3. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts;Kadono;J Rheumatol,1998

4. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis;Desallais;Arthritis Res Ther,2014

5. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis;De Lauretis;J Rheumatol,2013

Cited by 483 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial;Seminars in Arthritis and Rheumatism;2024-04

2. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention;Life;2024-02-06

3. Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013–2022;Rheumatology International;2024-02-06

4. Tocilizumab in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis;Annals of the American Thoracic Society;2024-02

5. Tree shrews as a new animal model for systemic sclerosis research;Frontiers in Immunology;2024-01-26